The regulation of human MMP-13 by licofelone, an inhibitor of cyclo-oxygenases and 5-lipoxygenase, in human osteoarthritic chondrocytes is mediated by the inhibition of the p38 MAP kinase signalling pathway

被引:49
作者
Boileau, C
Pelletier, JP
Tardif, G
Fahmi, H
Laufer, S
Lavigne, M
Martel-Pelletier, J
机构
[1] Univ Montreal, Notre Dame Hosp, Ctr Hosp, Osteoarthrit Res Unit, Montreal, PQ H2L 4M1, Canada
[2] Univ Tubingen, Tubingen, Germany
[3] Hop Maison Neuve Rosemont, Montreal, PQ H1T 2M4, Canada
关键词
D O I
10.1136/ard.2004.026906
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: MMP-13 is one of the most important metalloproteases (MMP) involved in osteoarthritis. Licofelone, a novel dual inhibitor of cyclo-oxygenases ( COX) and 5-lipoxygenase (5-LOX), can modulate MMP-13 production in human osteoarthritis chondrocytes. Objective: To evaluate the impact of licofelone on MMP-13 expression/production, promoter, and major MAP kinase signalling pathways and transcription factors. Methods: Human osteoarthritis chondrocytes were stimulated by interleukin 1 beta ( IL1 beta) and treated with or without: licofelone (0.3, 1, or 3 mg/ml); NS-398 ( 10 mu M; a specific COX-2 inhibitor); or BayX-1005 ( 10 mM; a specific 5-LOX inhibitor). MMP-13 synthesis was determined by specific enzyme linked immunosorbent assay, and expression by real time polymerase chain reaction. The effect of licofelone on the MMP-13 promoter was studied through transient transfection; dexamethasone ( 1027 M) was used as comparison. The effect on IL1 beta induced MMP-13 signalling pathways was determined using specific ELISA for phosphorylated MAP kinases and transcription factors. Results: Licofelone dose dependently inhibited the IL1 beta stimulated production and expression of MMP-13. NS-398 and BayX-1005 had very little effect. Licofelone also inhibited MMP-13 transcription on each of the promoter constructs used. The licofelone inhibition was comparable to that obtained with dexamethasone. Licofelone had no effect on phosphorylated p44/42 or JNK1/2; however, it decreased phosphorylated c-jun and inhibited phosphorylated p38, CREB, and AP-1 activity. Conclusions: Licofelone inhibited MMP-13 production under proinflammatory conditions on human osteoarthritis chondrocytes, through inhibition of the p38/AP-1 pathway and the transcription factor CREB. This may explain some of the mechanisms whereby licofelone exerts its positive effect on osteoarthritic changes.
引用
收藏
页码:891 / 898
页数:8
相关论文
共 55 条
  • [1] DEVELOPMENT OF CRITERIA FOR THE CLASSIFICATION AND REPORTING OF OSTEOARTHRITIS - CLASSIFICATION OF OSTEOARTHRITIS OF THE KNEE
    ALTMAN, R
    ASCH, E
    BLOCH, D
    BOLE, G
    BORENSTEIN, D
    BRANDT, K
    CHRISTY, W
    COOKE, TD
    GREENWALD, R
    HOCHBERG, M
    HOWELL, D
    KAPLAN, D
    KOOPMAN, W
    LONGLEY, S
    MANKIN, H
    MCSHANE, DJ
    MEDSGER, T
    MEENAN, R
    MIKKELSEN, W
    MOSKOWITZ, R
    MURPHY, W
    ROTHSCHILD, B
    SEGAL, M
    SOKOLOFF, L
    WOLFE, F
    [J]. ARTHRITIS AND RHEUMATISM, 1986, 29 (08): : 1039 - 1049
  • [2] Angel P, 1992, Matrix Suppl, V1, P156
  • [3] BINDING OF AP-1/CREB PROTEINS AND OF MDBP TO CONTIGUOUS SITES DOWNSTREAM OF THE HUMAN TGF-BETA-1 GENE
    ASIEDU, CK
    SCOTTO, L
    ASSOIAN, RK
    EHRLICH, M
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1994, 1219 (01): : 55 - 63
  • [4] The AP-1 site and MMP gene regulation: What is all the fuss about?
    Benbow, U
    Brinckerhoff, CE
    [J]. MATRIX BIOLOGY, 1997, 15 (8-9) : 519 - 526
  • [5] Benderdour M, 2002, J RHEUMATOL, V29, P1262
  • [6] A novel negative regulatory element in the human collagenase-3 proximal promoter region
    Benderdour, M
    Tardif, G
    Pelletier, JP
    Dupuis, M
    Geng, C
    Martel-Pelletier, J
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2002, 291 (05) : 1151 - 1159
  • [7] Boileau C, 2002, J RHEUMATOL, V29, P1446
  • [8] Caron JP, 1996, AM J VET RES, V57, P1631
  • [9] Anti-inflammatory drugs: New multitarget compounds to face an old problem. The dual inhibition concept
    Celotti, F
    Laufer, S
    [J]. PHARMACOLOGICAL RESEARCH, 2001, 43 (05) : 429 - 436
  • [10] A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammmatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate
    Crew, TE
    Elder, DJE
    Paraskeva, C
    [J]. CARCINOGENESIS, 2000, 21 (01) : 69 - 77